Intrinsic Value of S&P & Nasdaq Contact Us

PepGen Inc. PEPG NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
56/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$12.50
+639.6%

PepGen Inc. (PEPG) — Analyst outlook / Analyst consensus target is. Based on 6 analyst ratings, the consensus is bullish — 5 Buy, 1 Sell.

The consensus price target is $12.50 (low: $7.00, high: $18.00), representing an upside of 639.6% from the current price $1.69.

Analysts estimate Earnings Per Share (EPS) of $-2.73 and revenue of $0.00B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-2.85 vs est $-2.73 (missed -4.4%). 2025: actual $-2.12 vs est $-2.27 (beat +6.4%). Analyst accuracy: 94%.

PEPG Stock — 12-Month Price Forecast

$12.50
▲ +639.64% Upside
Average Price Target
Based on 6 Wall Street analysts offering 12-month price targets for PepGen Inc., the average price target is $12.50, with a high forecast of $18.00, and a low forecast of $7.00.
The average price target represents a +639.64% change from the last price of $1.69.
Highest Price Target
$18.00
Average Price Target
$12.50
Lowest Price Target
$7.00

PEPG Analyst Ratings

Buy
6
Ratings
5 Buy
1 Sell
Based on 6 analysts giving stock ratings to PepGen Inc. in the past 3 months
Rating breakdown
Buy
5 83%
Sell
1 17%
83%
Buy
5 analysts
0%
Hold
0 analysts
17%
Sell
1 analysts

EPS Estimates — PEPG

94%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual –$2.85 vs Est –$2.73 ▼ 4.2% off
2025 Actual –$2.12 vs Est –$2.27 ▲ 6.9% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.

Revenue Estimates — PEPG

Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message